Literature DB >> 30802343

CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines.

Nadja Raab1, Sven Mathias1, Kerstin Alt1,2, René Handrick1, Simon Fischer3, Valerie Schmieder4, Vaibhav Jadhav4, Nicole Borth4,5, Kerstin Otte1.   

Abstract

MicroRNAs (miRNAs) are noncoding RNAs that serve as versatile molecular engineering tools to improve production cells by overexpression or knockdown of miRNAs showing beneficial or adverse effects on cell-culture performance. The genomic knockout (KO) of noncoding RNAs in Chinese hamster ovary (CHO) production cells has not been reported. However, given the significant number of miRNAs showing negative effects on CHO-bioprocess performance and the development of clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins (CRISPR/Cas9), genome editing tools facilitate precise optimization of CHO cells via modulation of noncoding RNAs. In a previous high-content miRNA screen, miR-744 was identified as a potential target associated with reduced productivity. Hence, the genomic miR-744 precursor sequence is deleted by two single guide RNA (sgRNA)-Cas9-mediated DNA double-strand breaks (DSB) flanking the miR-744 locus. After fluorescence-activated cell sorting (FACS), clonal miR-744 KO cell lines are recovered and three of them are confirmed as miR-744 KOs. Impacts of CRISPR/Cas9 editing are characterized at the genetic, transcript, and phenotypic levels. During batch cultivation, antibody titers of miR-744 KOs are significantly increased to 190-311 mg L-1 compared to a nontargeting (NT) sgRNA transfected clonal control with 156 mg L-1 , pointing towards the potential of miRNA KO for cell line engineering.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CHO; CRISPR/Cas9; cell line engineering; knockout; microRNAs

Mesh:

Substances:

Year:  2019        PMID: 30802343     DOI: 10.1002/biot.201800477

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  6 in total

Review 1.  Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development.

Authors:  Nagesh K Tripathi; Ambuj Shrivastava
Journal:  Front Bioeng Biotechnol       Date:  2019-12-20

2.  Enhancing the yield of seasonal influenza viruses through manipulation of microRNAs in Madin-Darby canine kidney cells.

Authors:  Suthat Saengchoowong; Pattaraporn Nimsamer; Kritsada Khongnomnan; Witthaya Poomipak; Kesmanee Praianantathavorn; Somruthai Rattanaburi; Yong Poovorawan; Qibo Zhang; Sunchai Payungporn
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

Review 3.  Glycoengineering Chinese hamster ovary cells: a short history.

Authors:  Roberto Donini; Stuart M Haslam; Cleo Kontoravdi
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

4.  High throughput, efficacious gene editing & genome surveillance in Chinese hamster ovary cells.

Authors:  S C Huhn; Y Ou; A Kumar; R Liu; Z Du
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

Review 5.  The Effect of microRNA on the Production of Recombinant Protein in CHO Cells and its Mechanism.

Authors:  Hui-Ning Liu; Wei-Hua Dong; Yan Lin; Zhao-Hui Zhang; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-03-21

6.  Transferability of miRNA-technology to bioprocessing: Influence of cultivation mode and media.

Authors:  Ann-Cathrin Leroux; Elisabeth Bartels; Luise Winter; Melanie Mann; Kerstin Otte; Christoph Zehe
Journal:  Biotechnol Prog       Date:  2020-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.